Amarin Reports Record Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Operations

NEXT STORY
CytoDyn to Present New Data from Study of Investigational HIV Therapy Leronlimab (PRO 140), a Long-Acting, Single-Agent Maintenance Therapy at CROI 2019
PREV STORY
Severe Acute Respiratory Syndrome (SARS) Infection Drug Pipeline Study, H2 2018 – Analysis of Phases, Companies, Mechansim, Trials, & Current Status of Pipeline Drugs
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018

author_avatar
NASDAQ Market News

Cancer Genetics, Inc. Announces 15% Revenue Increase in First Quarter of 2017 over 2016 on Strong Organic Growth While Continuing on Path to Profitability

Revenue increased to $7.0 million in Q1 2017, up 15% compared to Q1 2016 ...

author_avatar
NASDAQ Market News

Global WholeHealth Partners with 1 Drop Inc. to Sell FDA EUA Approved COVID-19 rt-PCR in the US Market, as Mentioned in the July 16th 8K Filing

author_avatar
NASDAQ Market News